StockNews.com upgraded shares of Bausch Health Companies (NYSE:BHC – Free Report) from a hold rating to a buy rating in a report published on Wednesday morning. A number of other research analysts have also recently weighed in on BHC. Scotiabank dropped their price target on Bausch Health Companies from $10.00 to $8.50 and set a […]

Royal Bank of Canada cut shares of Kenvue (NYSE:KVUE – Free Report) from an outperform rating to a sector perform rating in a research report released on Tuesday, MarketBeat reports. The brokerage currently has $24.00 price target on the stock. KVUE has been the subject of a number of other research reports. Citigroup lowered their […]

Bausch + Lomb (NYSE:BLCO – Free Report) had its target price lifted by Stifel Nicolaus from $16.00 to $19.00 in a research note released on Monday, Benzinga reports. They currently have a hold rating on the stock. BLCO has been the topic of a number of other research reports. HC Wainwright lowered their price objective […]

Kenvue (NYSE:KVUE – Free Report) had its price objective increased by Piper Sandler from $20.00 to $21.00 in a report released on Monday, Benzinga reports. They currently have a neutral rating on the stock. KVUE has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of […]